Clinical Trial Update: Use of Tocilizumab Drug Levels to Optimize Treatment in RA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial exploring the use of tocilizumab drug levels to optimize treatment in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Reade Rheumatology Research Institute | Conditions: Rheumatoid Arthritis | Phase 4 | Status: RECRUITING